MOTS-C is a mitochondrial-derived peptide encoded in the 12S rRNA region, studied for AMPK pathway activation inside the cell
Then the program was shelved
Losing weight with tirzepatide can indeed lower the risk of kidney stones, especially for people who are overweight or obese
GLP-1s approved for diabetes include Mounjaro (tirzepatide), Ozempic (semaglutide), Rybelsus (oral semaglutide), Trulicity (dulaglutide), and Victoza (liraglutide)
It's important to note that Ozempic is not a cure for diabetes but rather a tool to help manage the condition effectively
[15] [19] Wegovy promotes weight loss partly by reducing appetite and food intake, which could theoretically exacerbate nutritional deficiencies if dietary quality is not maintained